Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
Status:
Completed
Trial end date:
2020-09-02
Target enrollment:
Participant gender:
Summary
This study is to evaluate effect and safety on central blood pressure with Duowell compared
to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.